Evidence map›Paper›PMID 40523461›Full record

ArticleBrain research2025

Regulation of LRRK2 activity by metabolic stress and heavy metal exposure.

Michalis Kentros, Jordan Follett, Nitya Subrahmanian, Aravindraja Chairmandurai, Katerina Melachroinou, Diane B Re, Rafael de Cabo, Ruth Chia, Jillian H Kluss, Alexandra Beilina and 5 more

Abstract read
In one paragraph

Article in Brain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Michalis KentrosCenter for Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation of the Academy of Athens, Greece.
Jordan FollettDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, USA; Center for Translational Research in Neurodegenerative Disease and Fixel Institute for Neurologic Diseases, Department of Neurology, University of Florida, Gainesville, FL, USA.
Nitya SubrahmanianDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, USA; Center for Translational Research in Neurodegenerative Disease and Fixel Institute for Neurologic Diseases, Department of Neurology, University of Florida, Gainesville, FL, USA.
Aravindraja ChairmanduraiDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, USA; Center for Translational Research in Neurodegenerative Disease and Fixel Institute for Neurologic Diseases, Department of Neurology, University of Florida, Gainesville, FL, USA.
Katerina MelachroinouCenter for Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation of the Academy of Athens, Greece.
Diane B ReDepartment of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
Rafael de CaboTranslational Gerontology Branch, NIA, NIH, MD, USA.
Ruth ChiaNeuromuscular Diseases Research Section, National Institute on Aging, Bethesda, MD, USA.
Jillian H KlussCell Biology and Gene Expression Section, NIA, NIH, MD, USA.
Alexandra BeilinaCell Biology and Gene Expression Section, NIA, NIH, MD, USA.
Heather MortiboysSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, United Kingdom.
Matthew J LaVoieDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, USA; Center for Translational Research in Neurodegenerative Disease and Fixel Institute for Neurologic Diseases, Department of Neurology, University of Florida, Gainesville, FL, USA.
Hardy J RideoutCenter for Clinical, Experimental Surgery, & Translational Research, Biomedical Research Foundation of the Academy of Athens, Greece.
Mark R CooksonCell Biology and Gene Expression Section, NIA, NIH, MD, USA.
Adamantios MamaisDepartment of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL, USA; Center for Translational Research in Neurodegenerative Disease and Fixel Institute for Neurologic Diseases, Department of Neurology, University of Florida, Gainesville, FL, USA. Electronic address: a.mamais@ufl.edu.

Funding

Dysregulation of iron homeostasis by mutant LRRK2 in human neuronsR21AG077269 · NIA · UNIVERSITY OF FLORIDA · PI MAMAIS, ADAMANTIOS · 2023 to 2024
$419k
NIA NIH HHS R21 AG077269
6 · The paper itself

Abstract

Genetic variability in the gene encoding leucine-rich repeat kinase 2 (LRRK2) is associated with both familial and sporadic Parkinson's disease (PD). While LRRK2 is known to modulate vesicular trafficking and stress signaling through its phosphorylation and kinase activity, how it responds to metabolic and environmental stressors remains poorly understood. Here, we show that acute inhibition of glycolysis and oxidative phosphorylation triggers rapid, reversible dephosphorylation of LRRK2 at constitutive sites in cells, ex vivo brain slices, and primary astrocytes. In contrast, glucose deprivation modestly increases LRRK2 kinase activity and Rab substrate phosphorylation. In vivo, chronic 2-deoxyglucose treatment reduces S935 phosphorylation in kidney tissue, linking energy stress to LRRK2 modulation in peripheral organs. Strikingly, manganese (Mn), a PD-relevant environmental toxicant, robustly activates LRRK2, inducing pS1292 autophosphorylation and phosphorylation of Rab8a, Rab10 and Rab12, while suppressing S935 phosphorylation after a 24 hrs exposure. Time-resolved analysis revealed distinct temporal substrate regulation, with rapid Rab12 phosphorylation and pRab10 levels gradually increasing and peaking only after 24 h. Phosphorylated Rab10 remains closely associated with both lysosomal and centrosomal membranes under Mn stress. Mn impaired mitochondrial respiration and increased ROS, and antioxidant treatment rescued Rab10 phosphorylation, establishing a redox-dependent mechanism of LRRK2 activation. Together, these findings reveal stressor-specific modes of LRRK2 regulation and suggest that LRRK2 integrates metabolic and environmental signals via redox-sensitive pathways relevant to PD pathogenesis.

Indexed as

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Stress, PhysiologicalAnimalsAstrocytesBrainCells, CulturedDeoxyglucoseGlucoseGlycolysisHumansMaleManganeseMiceMice, Inbred C57BLMitochondriaParkinson DiseaseDeoxyglucoseGlucoseLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Lrrk2 protein, mouseManganeserab GTP-Binding ProteinsLRRK2ManganeseMetabolic stress

Identifiers

PMID40523461
PMCPMC12947308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.